Thailand will soon start to produce nasal spray solutions that can prevent Covid-19 by Q3 2022.
The Government Pharmaceutical Organization (GPO) has been granted a certificate to start making the solution containing the human IgG1 Anti-SARS-CoV-2 antibody, said GPO director Rangsee Padlee on Thursday.
GPO’s nasal spray, in cooperation with the Chulalongkorn University, Silpakorn University, Health Systems Research Institute and High Bioscience Ltd., was introduced for trials in February.
It is in its last clinical trial phase conducted by the National Cancer Institute.
According to The Nation. the GPO had earlier been given the go-ahead by the Thai Food and Drug Administration.
“We are glad to offer people another option in preventing Covid-19, which will help Thailand overcome the pandemic in a safe, sustainable manner. Furthermore, the ISO certificate we received will pave the way for future research and manufacturing of new medicines for the treatment of respiratory diseases,” Rangsee said.
Source: The Nation
- PM Prayut advises people to work from home as PM2.5 increases - February 2, 2023
- Filipino singer Peter Rosalita receives a standing ovation on AGT All Stars - February 1, 2023
- Phu Hin Rong Kla records minus 1 degree Celsius - January 31, 2023